NCT01578486View on ClinicalTrials.gov

Salsalate as an Adjunctive Treatment for Patients With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

salsalate

open-label trial of salsalate 3g/day for 12 weeks.

Trial Locations (1)

01605

University of Massaschusetts Medical School, Worcester

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Massachusetts, Worcester

OTHER

NCT01578486 - Salsalate as an Adjunctive Treatment for Patients With Schizophrenia | Biotech Hunter | Biotech Hunter